|
JP4215219B2
(ja)
*
|
1997-07-04 |
2009-01-28 |
アンジェスＭｇ株式会社 |
脳保護剤
|
|
US6133308A
(en)
|
1997-08-15 |
2000-10-17 |
Millennium Pharmaceuticals, Inc. |
Synthesis of clasto-lactacystin beta-lactone and analogs thereof
|
|
US20090042807A1
(en)
*
|
1998-05-20 |
2009-02-12 |
Nisar Ahmed Khan |
Oligopeptide treatment of ischemia reperfusion injury
|
|
EP1138692A1
(en)
|
2000-03-29 |
2001-10-04 |
Erasmus Universiteit Rotterdam |
Fragments of human chorionic gonadotropin (hcg) as immunoregulator
|
|
US6844315B2
(en)
*
|
1998-05-20 |
2005-01-18 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
|
US7175679B2
(en)
|
2001-03-29 |
2007-02-13 |
Biotempt B.V. |
Oligopeptide treatment of NF-κB mediated inflammation
|
|
US6921751B1
(en)
|
1998-05-20 |
2005-07-26 |
Erasmus Universiteit Rotterdam |
Immunoregulator
|
|
US8680059B2
(en)
*
|
1998-05-20 |
2014-03-25 |
Biotempt B.V. |
Oligopeptide acetate and formulations thereof
|
|
US20030220258A1
(en)
*
|
2001-12-21 |
2003-11-27 |
Robbert Benner |
Treatment of ischemic events
|
|
EP1223948A2
(en)
*
|
1999-09-13 |
2002-07-24 |
CHARLOTTE-MECKLENBURG HOSPITAL doing business as Carolinas Medical Center |
Method of inhibiting nf-kappa-b with heparin, for treating cardiovascular diseases and inflammations
|
|
US7576174B2
(en)
|
2000-03-29 |
2009-08-18 |
Biotempt B.V. |
Compositions capable of reducing elevated blood urea concentration
|
|
EP1300418A1
(en)
*
|
2001-10-04 |
2003-04-09 |
Erasmus Universiteit Rotterdam |
Gene regulation by oligopeptides
|
|
US7358330B2
(en)
|
2001-03-29 |
2008-04-15 |
Biotempt B.V. |
Immunoregulatory compositions
|
|
USRE43279E1
(en)
|
2000-03-29 |
2012-03-27 |
Biotemp B.V. |
Compositions capable of reducing elevated blood urea concentration
|
|
US6713459B1
(en)
*
|
2000-04-28 |
2004-03-30 |
East Tennessee State University |
Methods for the prophylactic and therapeutic treatment of cardiac tissue damage
|
|
CA2429163C
(en)
*
|
2000-11-16 |
2013-02-12 |
The Regents Of The University Of California |
Marine actinomycete taxon for drug fermentation and product discovery
|
|
JP4162491B2
(ja)
|
2001-01-25 |
2008-10-08 |
アメリカ合衆国 |
ボロン酸化合物製剤
|
|
US7112588B2
(en)
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
|
US6740674B2
(en)
|
2001-05-21 |
2004-05-25 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
|
ATE502642T1
(de)
*
|
2001-10-05 |
2011-04-15 |
Zalicus Inc |
Kombinationen für die behandlung von immun- entzündlichen erkrankungen
|
|
ATE517617T1
(de)
*
|
2001-12-10 |
2011-08-15 |
Yansheng Dr Du |
Behandlung von parkinson erkrankung mit kape
|
|
US7560433B2
(en)
|
2001-12-21 |
2009-07-14 |
Biotempt B.V. |
Treatment of multiple sclerosis (MS)
|
|
US7786084B2
(en)
*
|
2001-12-21 |
2010-08-31 |
Biotempt B.V. |
Treatment of burns
|
|
US7501391B2
(en)
|
2001-12-21 |
2009-03-10 |
Biotempt B.V. |
Treatment of transplant survival
|
|
US20080242837A1
(en)
*
|
2001-12-21 |
2008-10-02 |
Khan Nisar A |
Peptide compositions
|
|
US20080318871A1
(en)
*
|
2001-12-21 |
2008-12-25 |
Khan Nisar A |
Treatment of neurological disorders
|
|
US7176232B2
(en)
|
2002-06-24 |
2007-02-13 |
The Regents Of The University Of California |
Salinosporamides and methods for use thereof
|
|
US7517529B2
(en)
*
|
2003-04-08 |
2009-04-14 |
Biotempt B.V. |
Treatment of type I diabetes
|
|
US20050004164A1
(en)
*
|
2003-04-30 |
2005-01-06 |
Caggiano Thomas J. |
2-Cyanopropanoic acid amide and ester derivatives and methods of their use
|
|
AU2004253478A1
(en)
*
|
2003-06-20 |
2005-01-13 |
Nereus Pharmaceuticals, Inc. |
Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases
|
|
ZA200600473B
(en)
*
|
2003-06-20 |
2007-04-25 |
Univ California |
Salinosporamides and methods for use thereof
|
|
US7348305B2
(en)
|
2003-08-28 |
2008-03-25 |
Department Of Veterans Affairs, Rehabilitation |
Inhibitor of cardiac tachyarrhythmias
|
|
US20090227505A1
(en)
*
|
2004-01-07 |
2009-09-10 |
Biotempt B.V. |
Methods and uses for protein breakdown products
|
|
SE0400399D0
(sv)
*
|
2004-02-20 |
2004-02-20 |
Index Pharmaceuticals Ab |
Methods and compositions for the treatment or prevention of secondary ischemic injury
|
|
US7579371B2
(en)
|
2004-04-30 |
2009-08-25 |
Nereus Pharmaceuticals, Inc. |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof
|
|
EP2266988A1
(en)
|
2004-04-30 |
2010-12-29 |
Nereus Pharmaceuticals, Inc. |
[3.2.0] Heterocyclic compounds and methods of using the same
|
|
US7425580B2
(en)
*
|
2004-05-19 |
2008-09-16 |
Wyeth |
(Diaryl-methyl)-malononitriles and their use as estrogen receptor ligands
|
|
EP1771194A2
(en)
*
|
2004-07-07 |
2007-04-11 |
Biodevelops Pharma Entwicklung GmbH |
Use of a deubiquitinating compound for enhancing the expression of membrane proteins on the cell surface
|
|
US20060008454A1
(en)
*
|
2004-07-07 |
2006-01-12 |
Dr. Helmut Brunar |
Use of a compound for enhancing the expression of membrane proteins on the cell surface
|
|
US20090191105A1
(en)
*
|
2004-08-30 |
2009-07-30 |
Kazuhiro Tanahashi |
Fractionation Apparatus
|
|
US20060167106A1
(en)
*
|
2004-11-19 |
2006-07-27 |
Mei Zhang |
Compounds acting at the centrosome
|
|
EP1830838B1
(en)
|
2004-12-03 |
2012-10-03 |
Dana-Farber Cancer Institute, Inc. |
Compositions and methods for treating neoplastic diseases
|
|
JP4846799B2
(ja)
*
|
2005-07-05 |
2011-12-28 |
バイオテンプト ベー．フェー． |
腫瘍の治療
|
|
EP1912664A2
(en)
*
|
2005-07-06 |
2008-04-23 |
Biodevelops Pharma Entwicklung GmbH |
Use of a compound for enhancing the expression of membrane proteins on the cell surface
|
|
WO2007011757A1
(en)
*
|
2005-07-14 |
2007-01-25 |
Myogen, Inc. |
Use of inhibitors of the ubiquitin proteasome pathway for increasing contractility of the heart
|
|
US7691896B2
(en)
*
|
2005-08-10 |
2010-04-06 |
President And Fellows Of Harvard College |
Analogs of salinosporamide A
|
|
EP1864692A1
(en)
*
|
2006-06-07 |
2007-12-12 |
Biotempt B.V. |
Use of peptides for the control of radiation injury
|
|
ES2293834B1
(es)
*
|
2006-07-20 |
2009-02-16 |
Consejo Superior Investig. Cientificas |
Compuesto con actividad inhibidora de las interacciones ubc13-uev, composiciones farmaceuticas que lo comprenden y sus aplicaciones terapeuticas.
|
|
WO2008095195A2
(en)
*
|
2007-02-02 |
2008-08-07 |
Nereus Pharmaceuticals, Inc. |
Lyophilized formulations of salinosporamide a
|
|
DK2120991T3
(da)
*
|
2007-02-12 |
2014-04-28 |
Biotempt Bv |
Behandling af traumatisk blødning med korte oligopeptider
|
|
US20080280968A1
(en)
*
|
2007-05-04 |
2008-11-13 |
Nereus Pharmaceuticals, Inc. |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof for treating infectious diseases
|
|
US7442830B1
(en)
|
2007-08-06 |
2008-10-28 |
Millenium Pharmaceuticals, Inc. |
Proteasome inhibitors
|
|
US8394816B2
(en)
|
2007-12-07 |
2013-03-12 |
Irene Ghobrial |
Methods of using [3.2.0] heterocyclic compounds and analogs thereof in treating Waldenstrom's Macroglobulinemia
|
|
WO2009140287A1
(en)
|
2008-05-12 |
2009-11-19 |
Nereus Pharmaceuticals, Inc. |
Salinosporamide derivatives as proteasome inhibitors
|
|
CA2727862C
(en)
|
2008-06-17 |
2016-04-19 |
Millennium Pharmaceuticals, Inc. |
Boronate ester compounds and pharmaceutical compositions thereof
|
|
AR075090A1
(es)
|
2008-09-29 |
2011-03-09 |
Millennium Pharm Inc |
Derivados de acido 1-amino-2-ciclobutiletilboronico inhibidores de proteosoma,utiles como agentes anticancerigenos, y composiciones farmaceuticas que los comprenden.
|
|
EP2305285A1
(en)
|
2009-09-29 |
2011-04-06 |
Julius-Maximilians-Universität Würzburg |
Means and methods for treating ischemic conditions
|
|
EP2527434B1
(en)
|
2010-01-22 |
2017-08-09 |
Japan Science and Technology Agency |
Probe reagent for measurement of proteolytic activity
|
|
US8513218B2
(en)
|
2010-03-31 |
2013-08-20 |
Millennium Pharmaceuticals, Inc. |
Derivatives of 1-amino-2-cyclopropylethylboronic acid
|
|
CN108498532B
(zh)
|
2012-05-09 |
2021-07-23 |
坎泰克斯制药股份有限公司 |
骨髓抑制的治疗
|
|
IN2013MU01431A
(https=)
|
2013-04-16 |
2015-06-26 |
Cipla Ltd |
|
|
EP3102585B1
(en)
|
2014-02-03 |
2021-05-19 |
Ohio State Innovation Foundation |
Boronic acid esters and pharmaceutical formulations thereof
|
|
TN2016000492A1
(en)
|
2014-05-20 |
2018-04-04 |
Millennium Pharm Inc |
Boron-containing proteasome inhibitors for use after primary cancer therapy.
|
|
US10052346B2
(en)
|
2015-02-17 |
2018-08-21 |
Cantex Pharmaceuticals, Inc. |
Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids
|
|
JP2018510859A
(ja)
|
2015-03-17 |
2018-04-19 |
レオン−ナノドラッグズ ゲーエムベーハー |
安定化されたボロン酸化合物を含むナノ粒子
|
|
US11897969B2
(en)
|
2017-10-26 |
2024-02-13 |
The Regents Of The University Of California |
Inhibition of oxidation-specific epitopes to treat ischemic reperfusion injury
|
|
WO2024194686A2
(en)
|
2023-03-17 |
2024-09-26 |
Oxitope Pharma B.V. |
Anti-phosphocholine antibodies and methods of use thereof
|